Glucosamine

What it is and how it is sold

Glucosamine sulfate and glucosamine hydrochloride are the two forms common in pet products. They are nutraceuticals, not drugs, regulated as supplements, not held to the same proof-of-efficacy bar as a prescription medication. Most products combine glucosamine with chondroitin sulfate, MSM, and sometimes EPA/DHA.

Honest assessment of the evidence

The evidence for oral glucosamine in canine osteoarthritis is mixed. Some clinical trials show modest improvement in lameness and owner-assessed pain; others show no effect over placebo. Meta-analyses generally conclude that the effect, if present, is small and inferior to NSAIDs or to EPA/DHA at therapeutic doses. Cat data are sparser and weaker.

Product quality compounds the uncertainty. Independent assays have found that some labeled glucosamine doses are not present at the stated concentration. A National Animal Supplement Council (NASC) seal is a minimum quality signal; it is not a guarantee of clinical effect.

When it makes sense to try

• Early or mild osteoarthritis where NSAIDs are not yet warranted or are contraindicated.
• As an adjunct to weight loss, EPA/DHA, and a structured exercise plan, never as a sole treatment for moderate-to-severe disease.
• When the owner is committed to a 6–8 week trial and willing to discontinue if no improvement is observed.

Why it matters

Glucosamine occupies a strange space, over-promised in marketing, under-supported by evidence, but cheap and low-risk enough to be a reasonable adjunct. The mistake is treating it as a substitute for the interventions with stronger data: weight loss, EPA/DHA, and, when needed, prescription analgesia.